<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d433" origId="Dolasetron"><sentence id="DrugDDI.d433.s0" origId="s0" text="The potential for clinically significant drug-drug interactions posed by dolasetron and hydrodolasetron appears to be low for drugs commonly used in chemotherapy or surgery, because hydrodolasetron is eliminated by multiple routes."><entity id="DrugDDI.d433.s0.e0" origId="s0.p3" charOffset="73-83" type="drug" text="dolasetron"/><entity id="DrugDDI.d433.s0.e1" origId="s0.p10" charOffset="126-131" type="drug" text="drugs"/><pair id="DrugDDI.d433.s0.p0" e1="DrugDDI.d433.s0.e0" e2="DrugDDI.d433.s0.e1" interaction="false"/></sentence><sentence id="DrugDDI.d433.s1" origId="s1" text="Blood levels of hydrodolasetron increased 24% when dolasetron was coadministered with cimetidine (nonselective inhibitor of cytochrome P-450) for 7 days, and decreased 28% with coadministration of rifampin (potent inducer of cytochrome P-450) for 7 days."><entity id="DrugDDI.d433.s1.e0" origId="s1.p25" charOffset="21-31" type="drug" text="dolasetron"/><entity id="DrugDDI.d433.s1.e1" origId="s1.p28" charOffset="86-96" type="drug" text="cimetidine"/><entity id="DrugDDI.d433.s1.e2" origId="s1.p31" charOffset="124-140" type="drug" text="cytochrome P-450"/><entity id="DrugDDI.d433.s1.e3" origId="s1.p38" charOffset="197-205" type="drug" text="rifampin"/><entity id="DrugDDI.d433.s1.e4" origId="s1.p41" charOffset="225-241" type="drug" text="cytochrome P-450"/><pair id="DrugDDI.d433.s1.p0" e1="DrugDDI.d433.s1.e0" e2="DrugDDI.d433.s1.e1" interaction="true"/><pair id="DrugDDI.d433.s1.p1" e1="DrugDDI.d433.s1.e0" e2="DrugDDI.d433.s1.e2" interaction="false"/><pair id="DrugDDI.d433.s1.p2" e1="DrugDDI.d433.s1.e0" e2="DrugDDI.d433.s1.e3" interaction="true"/><pair id="DrugDDI.d433.s1.p3" e1="DrugDDI.d433.s1.e0" e2="DrugDDI.d433.s1.e4" interaction="false"/><pair id="DrugDDI.d433.s1.p4" e1="DrugDDI.d433.s1.e1" e2="DrugDDI.d433.s1.e2" interaction="false"/><pair id="DrugDDI.d433.s1.p5" e1="DrugDDI.d433.s1.e1" e2="DrugDDI.d433.s1.e3" interaction="false"/><pair id="DrugDDI.d433.s1.p6" e1="DrugDDI.d433.s1.e1" e2="DrugDDI.d433.s1.e4" interaction="false"/><pair id="DrugDDI.d433.s1.p7" e1="DrugDDI.d433.s1.e2" e2="DrugDDI.d433.s1.e3" interaction="false"/><pair id="DrugDDI.d433.s1.p8" e1="DrugDDI.d433.s1.e2" e2="DrugDDI.d433.s1.e4" interaction="false"/><pair id="DrugDDI.d433.s1.p9" e1="DrugDDI.d433.s1.e3" e2="DrugDDI.d433.s1.e4" interaction="false"/></sentence><sentence id="DrugDDI.d433.s2" origId="s2" text="Dolasetron has been safely coadministered with drugs used in chemotherapy and surgery."><entity id="DrugDDI.d433.s2.e0" origId="s2.p44" charOffset="0-10" type="drug" text="Dolasetron"/><entity id="DrugDDI.d433.s2.e1" origId="s2.p49" charOffset="47-52" type="drug" text="drugs"/><pair id="DrugDDI.d433.s2.p0" e1="DrugDDI.d433.s2.e0" e2="DrugDDI.d433.s2.e1" interaction="false"/></sentence><sentence id="DrugDDI.d433.s3" origId="s3" text="As with other agents which prolong ECG intervals, caution should be exercised in patients taking drugs which prolong ECG intervals, particularly QTc."><entity id="DrugDDI.d433.s3.e0" origId="s3.p65" charOffset="97-102" type="drug" text="drugs"/></sentence><sentence id="DrugDDI.d433.s4" origId="s4" text="In patients taking furosemide, nifedipine, diltiazem, ACE inhibitors, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron."><entity id="DrugDDI.d433.s4.e0" origId="s4.p72" charOffset="19-29" type="drug" text="furosemide"/><entity id="DrugDDI.d433.s4.e1" origId="s4.p73" charOffset="31-41" type="drug" text="nifedipine"/><entity id="DrugDDI.d433.s4.e2" origId="s4.p74" charOffset="43-52" type="drug" text="diltiazem"/><entity id="DrugDDI.d433.s4.e3" origId="s4.p75" charOffset="54-68" type="drug" text="ACE inhibitors"/><entity id="DrugDDI.d433.s4.e4" origId="s4.p76" charOffset="70-79" type="drug" text="verapamil"/><entity id="DrugDDI.d433.s4.e5" origId="s4.p77" charOffset="81-90" type="drug" text="glyburide"/><entity id="DrugDDI.d433.s4.e6" origId="s4.p78" charOffset="92-103" type="drug" text="propranolol"/><entity id="DrugDDI.d433.s4.e7" origId="s4.p80" charOffset="117-136" type="drug" text="chemotherapy agents"/><pair id="DrugDDI.d433.s4.p0" e1="DrugDDI.d433.s4.e0" e2="DrugDDI.d433.s4.e1" interaction="false"/><pair id="DrugDDI.d433.s4.p1" e1="DrugDDI.d433.s4.e0" e2="DrugDDI.d433.s4.e2" interaction="false"/><pair id="DrugDDI.d433.s4.p2" e1="DrugDDI.d433.s4.e0" e2="DrugDDI.d433.s4.e3" interaction="false"/><pair id="DrugDDI.d433.s4.p3" e1="DrugDDI.d433.s4.e0" e2="DrugDDI.d433.s4.e4" interaction="false"/><pair id="DrugDDI.d433.s4.p4" e1="DrugDDI.d433.s4.e0" e2="DrugDDI.d433.s4.e5" interaction="false"/><pair id="DrugDDI.d433.s4.p5" e1="DrugDDI.d433.s4.e0" e2="DrugDDI.d433.s4.e6" interaction="false"/><pair id="DrugDDI.d433.s4.p6" e1="DrugDDI.d433.s4.e0" e2="DrugDDI.d433.s4.e7" interaction="false"/><pair id="DrugDDI.d433.s4.p7" e1="DrugDDI.d433.s4.e1" e2="DrugDDI.d433.s4.e2" interaction="false"/><pair id="DrugDDI.d433.s4.p8" e1="DrugDDI.d433.s4.e1" e2="DrugDDI.d433.s4.e3" interaction="false"/><pair id="DrugDDI.d433.s4.p9" e1="DrugDDI.d433.s4.e1" e2="DrugDDI.d433.s4.e4" interaction="false"/><pair id="DrugDDI.d433.s4.p10" e1="DrugDDI.d433.s4.e1" e2="DrugDDI.d433.s4.e5" interaction="false"/><pair id="DrugDDI.d433.s4.p11" e1="DrugDDI.d433.s4.e1" e2="DrugDDI.d433.s4.e6" interaction="false"/><pair id="DrugDDI.d433.s4.p12" e1="DrugDDI.d433.s4.e1" e2="DrugDDI.d433.s4.e7" interaction="false"/><pair id="DrugDDI.d433.s4.p13" e1="DrugDDI.d433.s4.e2" e2="DrugDDI.d433.s4.e3" interaction="false"/><pair id="DrugDDI.d433.s4.p14" e1="DrugDDI.d433.s4.e2" e2="DrugDDI.d433.s4.e4" interaction="false"/><pair id="DrugDDI.d433.s4.p15" e1="DrugDDI.d433.s4.e2" e2="DrugDDI.d433.s4.e5" interaction="false"/><pair id="DrugDDI.d433.s4.p16" e1="DrugDDI.d433.s4.e2" e2="DrugDDI.d433.s4.e6" interaction="false"/><pair id="DrugDDI.d433.s4.p17" e1="DrugDDI.d433.s4.e2" e2="DrugDDI.d433.s4.e7" interaction="false"/><pair id="DrugDDI.d433.s4.p18" e1="DrugDDI.d433.s4.e3" e2="DrugDDI.d433.s4.e4" interaction="false"/><pair id="DrugDDI.d433.s4.p19" e1="DrugDDI.d433.s4.e3" e2="DrugDDI.d433.s4.e5" interaction="false"/><pair id="DrugDDI.d433.s4.p20" e1="DrugDDI.d433.s4.e3" e2="DrugDDI.d433.s4.e6" interaction="false"/><pair id="DrugDDI.d433.s4.p21" e1="DrugDDI.d433.s4.e3" e2="DrugDDI.d433.s4.e7" interaction="false"/><pair id="DrugDDI.d433.s4.p22" e1="DrugDDI.d433.s4.e4" e2="DrugDDI.d433.s4.e5" interaction="false"/><pair id="DrugDDI.d433.s4.p23" e1="DrugDDI.d433.s4.e4" e2="DrugDDI.d433.s4.e6" interaction="false"/><pair id="DrugDDI.d433.s4.p24" e1="DrugDDI.d433.s4.e4" e2="DrugDDI.d433.s4.e7" interaction="false"/><pair id="DrugDDI.d433.s4.p25" e1="DrugDDI.d433.s4.e5" e2="DrugDDI.d433.s4.e6" interaction="false"/><pair id="DrugDDI.d433.s4.p26" e1="DrugDDI.d433.s4.e5" e2="DrugDDI.d433.s4.e7" interaction="false"/><pair id="DrugDDI.d433.s4.p27" e1="DrugDDI.d433.s4.e6" e2="DrugDDI.d433.s4.e7" interaction="false"/></sentence><sentence id="DrugDDI.d433.s5" origId="s5" text="Clearance of hydrodolasetron decreased by about 27% when dolasetron mesylate was administered intravenously concomitantly with atenolol."><entity id="DrugDDI.d433.s5.e0" origId="s5.p91" charOffset="57-76" type="drug" text="dolasetron mesylate"/><entity id="DrugDDI.d433.s5.e1" origId="s5.p95" charOffset="127-135" type="drug" text="atenolol"/><pair id="DrugDDI.d433.s5.p0" e1="DrugDDI.d433.s5.e0" e2="DrugDDI.d433.s5.e1" interaction="true"/></sentence><sentence id="DrugDDI.d433.s6" origId="s6" text="Dolasetron does not influence anesthesia recovery time in patients."><entity id="DrugDDI.d433.s6.e0" origId="s6.p96" charOffset="0-10" type="drug" text="Dolasetron"/></sentence><sentence id="DrugDDI.d433.s7" origId="s7" text="Dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents (cisplatin, 5-fluorouracil, doxorubicin, cyclophosphamide) in four murine models."><entity id="DrugDDI.d433.s7.e0" origId="s7.p102" charOffset="0-19" type="drug" text="Dolasetron mesylate"/><entity id="DrugDDI.d433.s7.e1" origId="s7.p107" charOffset="67-89" type="drug" text="chemotherapeutic agent"/><entity id="DrugDDI.d433.s7.e2" origId="s7.p109" charOffset="92-101" type="drug" text="cisplatin"/><entity id="DrugDDI.d433.s7.e3" origId="s7.p110" charOffset="103-117" type="drug" text="5-fluorouracil"/><entity id="DrugDDI.d433.s7.e4" origId="s7.p111" charOffset="119-130" type="drug" text="doxorubicin"/><entity id="DrugDDI.d433.s7.e5" origId="s7.p112" charOffset="132-148" type="drug" text="cyclophosphamide"/><pair id="DrugDDI.d433.s7.p0" e1="DrugDDI.d433.s7.e0" e2="DrugDDI.d433.s7.e1" interaction="false"/><pair id="DrugDDI.d433.s7.p1" e1="DrugDDI.d433.s7.e0" e2="DrugDDI.d433.s7.e2" interaction="false"/><pair id="DrugDDI.d433.s7.p2" e1="DrugDDI.d433.s7.e0" e2="DrugDDI.d433.s7.e3" interaction="false"/><pair id="DrugDDI.d433.s7.p3" e1="DrugDDI.d433.s7.e0" e2="DrugDDI.d433.s7.e4" interaction="false"/><pair id="DrugDDI.d433.s7.p4" e1="DrugDDI.d433.s7.e0" e2="DrugDDI.d433.s7.e5" interaction="false"/><pair id="DrugDDI.d433.s7.p5" e1="DrugDDI.d433.s7.e1" e2="DrugDDI.d433.s7.e2" interaction="false"/><pair id="DrugDDI.d433.s7.p6" e1="DrugDDI.d433.s7.e1" e2="DrugDDI.d433.s7.e3" interaction="false"/><pair id="DrugDDI.d433.s7.p7" e1="DrugDDI.d433.s7.e1" e2="DrugDDI.d433.s7.e4" interaction="false"/><pair id="DrugDDI.d433.s7.p8" e1="DrugDDI.d433.s7.e1" e2="DrugDDI.d433.s7.e5" interaction="false"/><pair id="DrugDDI.d433.s7.p9" e1="DrugDDI.d433.s7.e2" e2="DrugDDI.d433.s7.e3" interaction="false"/><pair id="DrugDDI.d433.s7.p10" e1="DrugDDI.d433.s7.e2" e2="DrugDDI.d433.s7.e4" interaction="false"/><pair id="DrugDDI.d433.s7.p11" e1="DrugDDI.d433.s7.e2" e2="DrugDDI.d433.s7.e5" interaction="false"/><pair id="DrugDDI.d433.s7.p12" e1="DrugDDI.d433.s7.e3" e2="DrugDDI.d433.s7.e4" interaction="false"/><pair id="DrugDDI.d433.s7.p13" e1="DrugDDI.d433.s7.e3" e2="DrugDDI.d433.s7.e5" interaction="false"/><pair id="DrugDDI.d433.s7.p14" e1="DrugDDI.d433.s7.e4" e2="DrugDDI.d433.s7.e5" interaction="false"/></sentence></document>